Ohshima, H.; Kobayashi, E.; Inaba, M.; Nakazawa, R.; Hirai, N.; Ueno, T.; Nakanishi, Y.; Endo, K.; Kondo, S.; Moriyama-Kita, M.;
et al. HRAS Mutations in Head and Neck Carcinomas in Japanese Patients: Clinical Significance, Prognosis, and Therapeutic Potential. Int. J. Mol. Sci. 2025, 26, 3093.
https://doi.org/10.3390/ijms26073093
AMA Style
Ohshima H, Kobayashi E, Inaba M, Nakazawa R, Hirai N, Ueno T, Nakanishi Y, Endo K, Kondo S, Moriyama-Kita M,
et al. HRAS Mutations in Head and Neck Carcinomas in Japanese Patients: Clinical Significance, Prognosis, and Therapeutic Potential. International Journal of Molecular Sciences. 2025; 26(7):3093.
https://doi.org/10.3390/ijms26073093
Chicago/Turabian Style
Ohshima, Hidemi, Eiji Kobayashi, Manabu Inaba, Ryotaro Nakazawa, Nobuyuki Hirai, Takayoshi Ueno, Yosuke Nakanishi, Kazuhira Endo, Satoru Kondo, Makiko Moriyama-Kita,
and et al. 2025. "HRAS Mutations in Head and Neck Carcinomas in Japanese Patients: Clinical Significance, Prognosis, and Therapeutic Potential" International Journal of Molecular Sciences 26, no. 7: 3093.
https://doi.org/10.3390/ijms26073093
APA Style
Ohshima, H., Kobayashi, E., Inaba, M., Nakazawa, R., Hirai, N., Ueno, T., Nakanishi, Y., Endo, K., Kondo, S., Moriyama-Kita, M., Sugimoto, H., & Yoshizaki, T.
(2025). HRAS Mutations in Head and Neck Carcinomas in Japanese Patients: Clinical Significance, Prognosis, and Therapeutic Potential. International Journal of Molecular Sciences, 26(7), 3093.
https://doi.org/10.3390/ijms26073093
